找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Clinician’s Manual: Treatment of Hypertension; Third Edition Franz H Messerli Book 2011Latest edition Springer Healthcare Ltd. 2011 Clinica

[復制鏈接]
樓主: intern
31#
發(fā)表于 2025-3-26 21:02:14 | 只看該作者
32#
發(fā)表于 2025-3-27 04:45:49 | 只看該作者
ce..Includes dozens of clear and informative tables and figures to maximize comprehension..Addresses the most recent?and crucial developments in a very common chronic condition..Gives a comprehensive review of currently available medications and combination therapy..Approximately one billion people
33#
發(fā)表于 2025-3-27 08:26:19 | 只看該作者
Conclusion: The Miscellarian Race, same dose of the same drug or combination, despite the fact that BP is not at goal. Any excuses volunteered by the patient (ie, crowded parking garage, mother-in-law visiting) seem good enough to rationalize that day’s high BP as an exception and delay further therapeutic intervention.
34#
發(fā)表于 2025-3-27 12:52:28 | 只看該作者
35#
發(fā)表于 2025-3-27 16:27:04 | 只看該作者
36#
發(fā)表于 2025-3-27 19:49:54 | 只看該作者
Fashions and fads,ngual application is of no added benefit because what gets into the blood stream is actually what is swallowed. Also, sublingual nifedipine lowers BP in a completely uncontrolled way, and such an abrupt BP drop has been associated with acute MI, stroke and death. Clearly, this is BP cosmetics and should be considered malpractice.
37#
發(fā)表于 2025-3-27 22:32:13 | 只看該作者
38#
發(fā)表于 2025-3-28 05:29:45 | 只看該作者
Evidence-based versus eminence-based therapy,that out of 100 screened patients with isolated systolic hypertension only one was included in the SHEP study and 99 were excluded for one reason or another. Can the evidence derived from 1% of the population be extrapolated to the remaining 99%?
39#
發(fā)表于 2025-3-28 10:14:13 | 只看該作者
https://doi.org/10.1007/978-1-907673-32-0Clinical; Professional; Reference; Cardiology
40#
發(fā)表于 2025-3-28 13:15:21 | 只看該作者
978-1-907673-08-5Springer Healthcare Ltd. 2011
 關于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結 SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-8 10:08
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權所有 All rights reserved
快速回復 返回頂部 返回列表
辰溪县| 大新县| 桃园市| 伊宁市| 宝坻区| 克拉玛依市| 轮台县| 涡阳县| 扶风县| 察隅县| 枞阳县| 大宁县| 金乡县| 黄浦区| 海淀区| 安福县| 青铜峡市| 德格县| 新巴尔虎左旗| 城市| 昆山市| 那坡县| 阜康市| 民和| 平安县| 南丰县| 新野县| 永和县| 镇赉县| 偃师市| 五指山市| 沧州市| 永清县| 洮南市| 赣榆县| 丰镇市| 开封市| 石城县| 昭平县| 扶绥县| 江门市|